Victory Capital Management Inc Lexicon Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 44,307 shares of LXRX stock, worth $46,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,307

Previous 45,341 2.28%

Holding current value

$46,965

Previous $76,000 9.21%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$1.51 - $2.39 $1,561 - $2,471	-1,034 Reduced 2.28%	44,307 $69,000
Q2 2024 Aug 05, 2024	BUY	$1.54 - $2.28 $21,516 - $31,856	13,972 Added 44.54%	45,341 $76,000
Q1 2024 May 03, 2024	SELL	$1.3 - $3.58 $1,063 - $2,928	-818 Reduced 2.54%	31,369 $75,000
Q4 2023 Feb 05, 2024	BUY	$1.0 - $1.53 $5,813 - $8,893	5,813 Added 22.04%	32,187 $49,000
Q3 2023 Nov 06, 2023	BUY	$1.06 - $2.33 $6,490 - $14,266	6,123 Added 30.24%	26,374 $28,000
Q2 2023 Jul 27, 2023	SELL	$2.15 - $3.49 $1,014 - $1,647	-472 Reduced 2.28%	20,251 $46,000
Q1 2023 May 02, 2023	BUY	$1.99 - $2.68 $597 - $804	300 Added 1.47%	20,723 $50,000
Q4 2022 Feb 09, 2023	SELL	$1.8 - $2.56 $18 - $25	-10 Reduced 0.05%	20,423 $39,000
Q3 2022 Nov 02, 2022	BUY	$1.94 - $3.43 $17,213 - $30,434	8,873 Added 76.76%	20,433 $49,000
Q2 2022 Aug 01, 2022	SELL	$1.31 - $2.69 $30 - $61	-23 Reduced 0.2%	11,560 $22,000
Q1 2022 May 04, 2022	SELL	$1.95 - $3.89 $31,917 - $63,671	-16,368 Reduced 58.56%	11,583 $21,000
Q4 2021 Feb 07, 2022	BUY	$3.81 - $6.16 $26,616 - $43,033	6,986 Added 33.32%	27,951 $110,000
Q3 2021 Nov 02, 2021	BUY	$3.38 - $5.35 $34,719 - $54,955	10,272 Added 96.06%	20,965 $101,000
Q2 2021 Aug 03, 2021	BUY	$4.12 - $5.87 $2,381 - $3,392	578 Added 5.71%	10,693 $49,000
Q1 2021 May 04, 2021	SELL	$3.45 - $9.09 $7,627 - $20,097	-2,211 Reduced 17.94%	10,115 $59,000
Q4 2020 Feb 01, 2021	BUY	$1.05 - $3.67 $12,942 - $45,236	12,326 New	12,326 $42,000
Q2 2020 Aug 07, 2020	SELL	$1.75 - $2.3 $94,444 - $124,126	-53,968 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.8 - $4.28 $6,773 - $16,105	3,763 Added 7.5%	53,968 $105,000
Q4 2019 Feb 06, 2020	SELL	$3.16 - $5.15 $11,761 - $19,168	-3,722 Reduced 6.9%	50,205 $208,000
Q4 2019 Feb 04, 2020	SELL	$3.16 - $5.15 $8,190 - $13,348	-2,592 Reduced 4.59%	53,927 $167,000
Q3 2019 Nov 12, 2019	BUY	$1.2 - $6.66 $66,016 - $366,393	55,014 Added 3655.42%	56,519 $170,000
Q4 2018 Feb 05, 2019	SELL	$6.15 - $10.51 $1,765 - $3,016	-287 Reduced 16.02%	1,505 $10,000
Q3 2018 Nov 01, 2018	SELL	$10.32 - $13.06 $825,754 - $1.04 Million	-80,015 Reduced 97.81%	1,792 $19,000
Q2 2018 Aug 02, 2018	SELL	$7.8 - $13.69 $35,256 - $61,878	-4,520 Reduced 5.24%	81,807 $982,000
Q1 2018 May 04, 2018	BUY	$7.86 - $11.39 $666,292 - $965,530	84,770 Added 5444.44%	86,327 $739,000
Q2 2017 Aug 07, 2017	BUY	N/A	1,557	1,557 $26,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $200M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Lexicon Pharmaceuticals, Inc. Transaction History